ImpediMed Limited
IPDQF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $13 | $10 | $11 | $10 |
| % Growth | 26.6% | -11.4% | 8.1% | – |
| Cost of Goods Sold | $2 | $1 | $25 | $2 |
| Gross Profit | $11 | $9 | -$14 | $9 |
| % Margin | 86.3% | 86.9% | -120.4% | 83.7% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $22 | $22 | $20 | $18 |
| SG&A Expenses | $22 | $23 | $20 | $19 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $1 |
| Other Operating Expenses | $13 | $0 | $2 | $2 |
| Operating Expenses | $35 | $33 | $9 | $30 |
| Operating Income | -$24 | -$24 | -$23 | -$22 |
| % Margin | -190.4% | -241.8% | -201.4% | -205.2% |
| Other Income/Exp. Net | $1 | $5 | -$2 | -$3 |
| Pre-Tax Income | -$23 | -$20 | -$22 | -$20 |
| Tax Expense | $0 | $0 | -$2 | $0 |
| Net Income | -$23 | -$20 | -$21 | -$20 |
| % Margin | -182.6% | -196.9% | -180.9% | -189.4% |
| EPS | -0.012 | -0.01 | -0.011 | -0.012 |
| % Growth | -17.3% | 14% | 3.4% | – |
| EPS Diluted | -0.012 | -0.01 | -0.011 | -0.012 |
| Weighted Avg Shares Out | 2,019 | 2,022 | 1,800 | 1,679 |
| Weighted Avg Shares Out Dil | 2,019 | 2,022 | 1,800 | 1,679 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $1 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $2 | $2 | $3 |
| EBITDA | -$18 | -$22 | -$20 | -$19 |
| % Margin | -138% | -219.3% | -180.7% | -178.8% |